11/26
06:43 am
eypt
Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
11/6
10:52 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT
11/6
10:52 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT